The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices
- 1 May 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (9), 4652-4661
- https://doi.org/10.1158/0008-5472.can-05-1245
Abstract
Dipeptidyl peptidase IV (DPP4/CD26) and seprase/fibroblast activation protein α are homologous type II transmembrane, homodimeric glycoproteins that exhibit unique prolyl peptidase activities. Human DPP4 is ubiquitously expressed in epithelial and endothelial cells and serves multiple functions in cleaving the penultimate positioned prolyl bonds at the NH2 terminus of a variety of physiologically important peptides in the circulation. Recent studies showed a linkage between DPP4 and down-regulation of certain chemokines and mitogenic growth factors, and degradation of denatured collagens (gelatin), suggesting a role of DPP4 in the cell invasive phenotype. Here, we found the existence of a novel protease complex consisting of DPP4 and seprase in human endothelial cells that were activated to migrate and invade in the extracellular matrix in vitro. DPP4 and seprase were coexpressed with the three major protease systems (matrix metalloproteinase, plasminogen activator, and type II transmembrane serine protease) at the cell surface and organize as a complex at invadopodia-like protrusions. Both proteases were colocalized at the endothelial cells of capillaries, but not large blood vessels, in invasive breast ductal carcinoma in vivo. Importantly, monoclonal antibodies against the gelatin-binding domain of DPP4 blocked the local gelatin degradation by endothelial cells in the presence of the major metallo- and serine protease systems that modified pericellular collagenous matrices and subsequent cell migration and invasion. Thus, we have identified a novel mechanism involving the DPP4 gelatin-binding domain of the DPP4-seprase complex that facilitates the local degradation of the extracellular matrix and the invasion of the endothelial cells into collagenous matrices. (Cancer Res 2006; 66(9); 4652-61)Keywords
This publication has 42 references indexed in Scilit:
- Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling PathwayCancer Research, 2005
- Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast CancerCancer Research, 2004
- The Expression of a Type II Transmembrane Serine Protease (Seprase) in Human Gastric CarcinomaOncology, 2004
- Regulation of Fibroblast Migration on Collagenous Matrix by a Cell Surface Peptidase ComplexJournal of Biological Chemistry, 2002
- Type II Transmembrane Serine ProteasesJournal of Biological Chemistry, 2001
- A Novel Protease-docking Function of Integrin at InvadopodiaJournal of Biological Chemistry, 1999
- Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of ‘benign’ thyroid tumorPathology International, 1999
- Identification of the 170-kDa Melanoma Membrane-bound Gelatinase (Seprase) as a Serine Integral Membrane ProteaseJournal of Biological Chemistry, 1997
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Induction of spreading during fibroblast movement.The Journal of cell biology, 1979